BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 306 filers reported holding BLUEBIRD BIO INC in Q1 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $413,000 | -27.7% | 2,400 | -81.8% | 0.10% | +29.1% |
Q2 2016 | $571,000 | -31.1% | 13,200 | -32.3% | 0.08% | -17.7% |
Q1 2016 | $829,000 | -60.0% | 19,500 | -19.4% | 0.10% | -59.5% |
Q3 2015 | $2,070,000 | +5.4% | 24,202 | +107.5% | 0.24% | -9.9% |
Q2 2015 | $1,964,000 | – | 11,662 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |